Managing advanced-stage cervical cancer

Allen, David W.; Narayan, K.

doi:10.1016/j.bpobgyn.2005.03.001

Cited by 10 publications

(5 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ce lien est communé ment admis [10,[14][15][16][17]. Nous ne sommes pas parvenus à retrouver un lien similaire entre ces paramè tres et la survie sans ré cidive.…”

Section: Discussionunclassified

Intérêt pronostique de la TEP-TDM au 18F-FDG dans le bilan initial du cancer du col de l’utérus : étude rétrospective de 53 cas

Chastan

Manrique

Baron

et al. 2010

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

“…Ce lien est communé ment admis [10,[14][15][16][17]. Nous ne sommes pas parvenus à retrouver un lien similaire entre ces paramè tres et la survie sans ré cidive.…”

Section: Discussionunclassified

Intérêt pronostique de la TEP-TDM au 18F-FDG dans le bilan initial du cancer du col de l’utérus : étude rétrospective de 53 cas

Chastan

Manrique

Baron

et al. 2010

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

“…The BT protocol consists of five fractions of HDR BT following the completion of external beam radiotherapy (EBRT) with concurrent chemotherapy 8 . This is to take advantage of the effects of chemoradiotherapy on the tumour volume, in particular tumour shrinkage, enabling consistent and reproducible insertion of the applicator 9 .…”

Section: Methodsmentioning

confidence: 99%

Ultrasound‐based conformal planning for gynaecological brachytherapy

Dyk¹,

Bernshaw²

2008

J Med Imag Rad Onc

View full text Add to dashboard Cite

SUMMARYThis report describes the evolving use of transabdominal ultrasound (TAUS) as an imaging tool to verify tandem placement, localize the treatment volume and aid conformal brachytherapy planning for both cervical and uterine corpus cancers. Two patients, one with cancer of the cervix and one with cancer of the endometrium, are used as examples to illustrate the advantages of using TAUS. TAUS is used to guide applicator insertion and check the applicator in the treatment position. The dimensions of the uterus are recorded. Brachytherapy isodose plans are generated based on these measurements. Confirmation of uterine dimensions and isodose coverage is obtained using MRI taken after the initial fraction of treatment has been delivered. We illustrate how TAUS is successfully used to correct and verify tandem placement after the patient has been moved from insertion to treatment position. We also show how to use TAUS for conformal planning, based on individually derived target dimensions. TAUS has successfully been used to conformally plan treatment to the uterus and cervix, minimizing brachytherapyrelated toxicity to surrounding structures. Ultrasound is portable, inexpensive and simple to use and allows for accurate, conformal, reproducible and adaptive treatments.

show abstract

“…Worldwide cervical cancer is the third most common cancer affecting women, in terms of incidence and mortality rates [1,2], however in some parts of the world including India, it is the most common cancer in women [3][4][5]. Around one sixth to one fifth worldwide cases of cervical cancer occur in India [2][3][4][5][6]7].…”

Section: Introductionmentioning

confidence: 99%

Staging Issues in Cervical Cancer

Chhabra¹,

Devi²,

Chopra³

et al. 2017

Cancer Surg

View full text Add to dashboard Cite

Background: Worldwide cervical cancer is third most common cancer, but diagnostic, therapeutic problems continue in developing countries where it is most common cancer in women. Very few women report at operable stage. For those subjected to surgery, intraoperative findings, histopathology provides information for continuing or abandoning surgery, adjuvant therapy after surgery and so on. However clinical investigative staging may not be correct, leading to avoidable morbidity of surgery.

show abstract

Managing advanced-stage cervical cancer

Cited by 10 publications

References 38 publications

Intérêt pronostique de la TEP-TDM au 18F-FDG dans le bilan initial du cancer du col de l’utérus : étude rétrospective de 53 cas

Intérêt pronostique de la TEP-TDM au 18F-FDG dans le bilan initial du cancer du col de l’utérus : étude rétrospective de 53 cas

Ultrasound‐based conformal planning for gynaecological brachytherapy

Staging Issues in Cervical Cancer

Contact Info

Product

Resources

About